Overview of Lesetrin

Property	Description
Active Ingredient	Levocetirizine
Pharmacological Class	Second-generation antihistamine; H1-receptor antagonist
Form	Film-coated tablet, Oral solution
Route of Administration	Oral
Origin	Synthetic, derived from Cetirizine

What Type of Medicine is Lesetrin?

Lesetrin is a synthetic pharmaceutical product containing the active ingredient Levocetirizine, which is classified as a highly selective H1-receptor antagonist and belongs to the second-generation antihistamine class. This drug is noteworthy because it is the purified, single (R)-enantiomer—the biologically active component—of the older, racemic compound, Cetirizine. Pharmacological studies have consistently confirmed the selective nature of this compound, which is clinically recognized for its targeted action on peripheral H1-receptors.

Composition and Physical Form

Lesetrin is manufactured as a single-ingredient product where the core substance is Levocetirizine dihydrochloride. The medication is formulated for oral administration and is supplied in two primary dosage forms: a film-coated tablet and an oral solution. The composition relies on the active drug combined with standard pharmaceutical excipients necessary for creating the final preparation. This dual availability is key, as the solution often accommodates various patient needs, such as for individuals, including pediatric patients, who may require an easily measured liquid form.

What is the General Purpose of Antihistamines like Lesetrin?

The general purpose of Lesetrin is to provide symptomatic relief by directly interfering with the body's allergic response through its potent histamine-blocking action. Levocetirizine is effective in antagonizing peripheral H1-receptors. This action allows Lesetrin to fundamentally control the physiological manifestations of allergic conditions, such as local irritation and inflammation, by interrupting the initiation of the inflammatory cascade.

What side effects are possible with Lesetrin?

Possible Side Effects and Safety Information

Lesetrin (levocetirizine) has a safety profile documented through clinical trials and postmarketing surveillance, with potential adverse reactions officially classified by frequency and system-organ class in regulatory documents.

Frequency-Classified Adverse Reactions

The most Common (geq1/100 to <1/10) adverse reactions include somnolence (drowsiness), fatigue, dry mouth, nasopharyngitis, and pharyngitis. Reactions classified as Uncommon (geq1/1,000 to <1/100) include asthenia (weakness), abdominal pain, and certain skin reactions like pruritus (itching) and rash. Effects such as hypersensitivity, hallucinations, tremor, tachycardia, and urinary retention have been documented in postmarketing reports, categorized as Frequency Not Known.

Serious Adverse Reactions and Systemic Safety

Official labeling documents emphasize the potential for rare but serious reactions, including anaphylaxis and angioneurotic oedema, which fall under Immune System Disorders. Effects on the Nervous System include the potential for convulsion or seizure aggravation, and the Renal and Urinary System may be affected, specifically noting the risk of urinary retention.

Regulatory Safety Considerations

Safety constraints noted in regulatory texts include the contraindication of Lesetrin in individuals with known hypersensitivity to levocetirizine, cetirizine, or hydroxyzine, as well as in patients with End-Stage Renal Disease or severe renal impairment in certain pediatric groups. Caution is advised for individuals with predisposing factors for urinary retention, such as prostatic hyperplasia. The product label also specifies a pattern of severe pruritus reported upon cessation following long-term daily use.

Overdose and Emergency Response

Lesetrin Overdose and When to Seek Help

Immediate medical attention must be sought for any suspected overdose of Lesetrin, as mandated by official regulatory guidance. These instructions emphasize the necessity of professional intervention to manage the documented clinical presentations.

Documented Overdose Manifestations

Regulatory documents state that an overdose of the active ingredient, levocetirizine, primarily results in central nervous system (CNS) effects. The characteristic presentation differs depending on the patient's age:

In adults, the most commonly documented sign is pronounced drowsiness (somnolence).
In children, the presentation is typically biphasic, beginning with agitation and restlessness, which is subsequently followed by a state of drowsiness. These specific signs are detailed within the official product labeling.

Required Emergency Actions and Management

Official regulatory statements confirm that there is no known specific antidote available to counteract the effects of Levocetirizine overdose. Due to this constraint, the management of overdose is restricted to symptomatic and supportive treatment provided by a healthcare professional in a monitored setting.

Furthermore, regulatory guidance notes that the drug cannot be effectively removed from the body by dialysis. These regulatory facts underscore the critical importance of seeking medical assistance immediately upon suspicion of a dose exceeding prescribed limits.

Therapeutic Uses of Lesetrin

Main Uses and Benefits of Lesetrin

Lesetrin is a second-generation antihistamine used to manage symptoms associated with allergic reactions. Its primary function is to block the activity of histamine, a natural substance in the body that triggers allergic responses when the immune system reacts to external allergens.

Relief of Allergic Rhinitis

Lesetrin is primarily indicated for the treatment of allergic rhinitis, which includes both seasonal allergies and perennial (year-round) allergies. It helps reduce the following symptoms:

Nasal symptoms: It eases sneezing, an itchy or runny nose, and nasal congestion.
Ocular symptoms: It assists in relieving itchy, red, and watery eyes often caused by pollen, mold, or pet dander.

Management of Chronic Urticaria

Beyond respiratory allergies, Lesetrin is used to treat chronic idiopathic urticaria, a condition characterized by the frequent appearance of hives (red, itchy welts on the skin) without a clearly identifiable cause. The medication works to:

Reduce the number and size of hives.
Alleviate the persistent itching associated with skin allergic reactions.

Key Benefits

As a second-generation antihistamine, Lesetrin offers several specific benefits for patients managing chronic or acute allergy symptoms:

Rapid Onset of Action: The medication is generally absorbed quickly, providing relief within a short timeframe after administration.
Extended Duration: Its effects typically last for 24 hours, allowing for a once-daily dosing schedule that maintains symptom control throughout the day and night.
Reduced Sedation: Compared to first-generation antihistamines, Lesetrin is designed to have a lower potential for crossing the blood-brain barrier, which results in a significantly reduced likelihood of causing drowsiness or impairing daily activities.

Regulatory References

NIH MedlinePlus overview on Levocetirizine

Eligibility and Restrictions for Use

Who Can and Cannot Use Lesetrin?

The eligibility for using Lesetrin (Levocetirizine) is strictly defined by regulatory authorities based on age, organ function, and medical history.

Contraindicated Populations (Must Not Use)

Lesetrin is contraindicated and must not be used by patients who have a known hypersensitivity to levocetirizine, its parent compound cetirizine, or any component of the formulation. It is also prohibited for patients with end-stage renal disease (creatinine clearance < 10 mL/min) and for children (6 months to 11 years) with impaired renal function.

Age-Related Eligibility

The medicine is generally approved for use in adults and adolescents 12 years of age and older. It is also approved for pediatric patients from 6 months of age (using the oral solution). The safety and efficacy are not established in infants younger than six months old.

Use Restrictions and Caution

Use is restricted in adults and adolescents with mild, moderate, or severe renal impairment; these patients require a mandated dose adjustment due to the drug's primary excretion route. Caution is also advised for patients with predisposing factors for urinary retention, such as prostatic hyperplasia, or those with epilepsy due to the potential risk of convulsions. For pregnant or breastfeeding women, the drug should be used only if clearly needed, and caution is advised regarding its excretion into breast milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific restrictions for Lesetrin (levocetirizine) use based on documented pharmacokinetic and pharmacodynamic interactions. Co-administration of Lesetrin with Alcohol or other Central Nervous System (CNS) Depressants, such as sedatives or tranquilizers, must be avoided. This restriction is due to a pharmacodynamic interaction that may result in an additive reduction in alertness and impairment of CNS performance.

Pharmacokinetic Interactions

Lesetrin is generally unlikely to produce pharmacokinetic interactions through inhibition or induction of liver drug-metabolizing enzymes (CYP isoforms), as the drug is minimally metabolized. Studies with the racemic parent compound, Cetirizine, showed that co-administration with Ritonavir resulted in a 42% increase in plasma exposure (AUC) and a significant decrease in clearance of Cetirizine. A smaller reduction in clearance was also noted with Theophylline co-administration.

Interactions with Food and Patient Populations

Lesetrin may be taken with or without food. Although food does not affect the total extent of absorption (AUC), it officially results in a 36% lower maximum concentration (C max) and a delay in time to maximum concentration (T max). Due to the drug’s substantial renal excretion, the risk of adverse effects from accumulation is greater in patients with impaired renal function. Lesetrin is contraindicated in adult patients with End-Stage Renal Disease and those undergoing dialysis.

Mechanism of Action

How Lesetrin Works

Lesetrin's action involves receptor- or enzyme-mediated signaling, primarily by binding to and influencing specific receptor subtypes within the central nervous system. This direct engagement modifies the initiation or suppression of subsequent neuronal activity. The drug functions as a modulator by selectively engaging these targets, thereby intervening early in the molecular cascade.

The drug works by modulating key pathways associated with heightened physiological responses, particularly those driven by distinct signaling patterns involving excitatory neurotransmitters or mediators. By altering pathway activity, Lesetrin influences these pathways, shaping subsequent systemic physiological effects. A core mechanistic domain is the drug's ability to engage mechanisms that regulate overactive or dysregulated processes driven by excessive mediator activity. This intervention within the signaling cascades alters the effect of overstimulation, leading to predictable physiological adjustments within targeted pathways.

Dosage and Administration Information

How to Use Lesetrin: Official Administration Guidelines

Lesetrin (levocetirizine) is formulated for oral administration and is supplied as an immediate-release 5 mg film-coated tablet and an oral solution (0.5 mg/mL). The medicine is designed to be taken once daily (QD), and the intake is typically recommended to occur in the evening.

Standard Dosing and Administration

The full daily dose should be taken as a single intake, and the maximum recommended daily dose for the respective age group should not be exceeded. The tablet may be taken with or without food. For the 5 mg film-coated tablet, it must be swallowed whole with liquid; the tablet is scored to allow for breaking when administering the 2.5 mg dose.

Age Group	Standard Daily Dose	Note on Formulation
Adults and Adolescents (ge 12 years)	5 mg	2.5 mg may be adequate for some patients.
Children (6 to 11 years)	2.5 mg	Tablet or 5 mL oral solution.
Children (6 months to 5 years)	1.25 mg	Administered via oral solution.

Usage Patterns and Special Conditions

For patients with intermittent symptoms, treatment may be stopped when relief is achieved and restarted when symptoms reappear. Continuous use for periods of at least six months is supported by clinical experience for persistent conditions. A critical administrative protocol is the adjustment of the dosing interval for patients with renal impairment, which is based on their creatinine clearance. For example, patients with moderate renal impairment are advised to take the 2.5 mg dose once every other day, while no dose adjustment is necessary for patients with solely hepatic impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lesetrin

The understanding of Lesetrin’s effect on allergic symptoms is drawn from a body of formal clinical research. This overview describes the research landscape, including the types of studies conducted, what outcomes they measured, and areas where evidence remains limited or uncertain.

Evidence for Use in Seasonal and Perennial Allergic Rhinitis

Research examining Lesetrin for use in conditions like allergic rhinitis has primarily utilized randomized, double-blind, placebo-controlled trials. This research was studied for adults, adolescents, and pediatric patients (down to 6 months of age). Studies tracked Total Symptom Scores (TSS), which reflect nasal and ocular symptoms, along with quality of life. Findings show patterns related to measurements obtained across the majority of major trials, though one large trial reported outcomes that were noted as being mixed.

Evidence for Use in Chronic Urticaria (Hives)

For chronic urticaria, Lesetrin was evaluated in short-term, randomized, placebo-controlled trials. This research explored short-term symptom changes, focusing on Pruritus Severity Scores and tracking the number and size of wheals (hives). Regulatory evidence contributes to understanding symptom patterns over the short term.

Studies Tracking Long-Term Use and Sustained Relief

Research concerning long-term effects are not fully established or assessed over extended durations (longer than six months). While some observational settings were conducted, comprehensive trials designed to assess the durability of observed changes over many months are not fully established.

Research in Specific Patient Groups

Lesetrin was studied for a range of patient demographics, including core adult and adolescent groups. Data for certain groups remain insufficient, specifically for infants younger than 6 months of age and for the older adult population, compared to the core adult groups.

Areas of Research Uncertainty and Gaps

Follow-up durations were limited in many of the core efficacy studies, meaning there is limited information for long-term outcomes. Research provides limited insight into outcomes reflecting daily functioning when the compound is taken during the day, as pivotal trials often used evening dosing. Evidence quality varies across studies, and data for certain groups remain insufficient.

Key Studies & References Public Assessment Report Decentralised Procedure - Levocetirizine dihydrochloride 5 mg film-coated tablets

Frequently Asked Questions (FAQ)

Common questions about Lesetrin (FAQ)

Q: What is the main difference between Lesetrin and other similar medicines?

Official information explains that Lesetrin contains levocetirizine, which is the single, purified active component (the R-enantiomer) of the older antihistamine, cetirizine. It belongs to the class of second-generation antihistamines, which are clinically recognized for their targeted action.

Q: Is Lesetrin considered a maintenance medication?

Regulatory documents indicate that Lesetrin is approved for the treatment of long-lasting conditions, such as persistent allergic rhinitis and chronic idiopathic urticaria. For these persistent conditions, continuous use, sometimes for periods of at least six months, is noted in the official guidance.

Q: What happens if I miss a day of Lesetrin?

According to the official patient information, if a dose is missed, it can be taken as soon as the patient remembers. However, if it is almost time for the next scheduled dose, the official patient information describes a process where the missed dose is skipped, and the regular schedule is continued. The guidance notes that a double dose should not be taken to make up for a missed one.

Q: What are the most common reasons a patient might need to stop taking Lesetrin?

Patients may discontinue the medicine due to certain common side effects, such as drowsiness or fatigue, which are listed in official adverse reaction reports. Furthermore, official safety warnings note that patients who have taken the medicine daily for a long time may experience severe itching, known as pruritus, upon stopping.

Q: Are there different strengths or forms of Lesetrin available?

Lesetrin is available as a 5 mg film-coated tablet and an oral solution (0.5 mg/mL). Official instructions also clarify that the 5 mg tablet is scored, allowing the 2.5 mg dose to be administered by splitting the tablet.

Q: Is Lesetrin meant to cure the condition or just manage symptoms?

The use of Lesetrin, as defined in regulatory documents, is to provide symptomatic treatment for conditions like allergic rhinitis and chronic urticaria. This means its primary role is to help manage and relieve the symptoms associated with the condition.

Q: Does taking Lesetrin require any regular blood tests or monitoring?

Official regulatory information does not mandate routine blood tests for all patients taking Lesetrin. However, dose adjustment is specifically required for patients with renal (kidney) impairment, which is typically determined by measurements such as creatinine clearance.

Q: Is Lesetrin often started at a low amount and then increased?

The recommended daily dose for adults is 5 mg, but regulatory documents note that 2.5 mg may be sufficient for some patients, including those with milder symptoms or mild kidney impairment. A mandatory initial schedule of starting low and then increasing the dose is not described in the official labeling.

Q: Is it better to take Lesetrin in the morning or evening?

The official dosing instructions state that Lesetrin should be taken once daily in the evening. Official guidance often recommends evening dosing to align with clinical trial usage and to help manage potential side effects.

Q: What happens if Lesetrin is taken with certain antifungals?

Official documents state that Lesetrin is generally considered unlikely to be involved in drug interactions that happen through liver drug-metabolizing enzymes (known as CYP isoforms). This is because the drug itself is minimally broken down by the liver.

Q: If I am taking over-the-counter pain relievers, can I still take Lesetrin?

Drug interaction studies reviewed in official documentation have indicated that no significant pharmacokinetic interactions have been documented when Lesetrin is taken alongside common over-the-counter pain relievers such as acetaminophen.

Q: Is Lesetrin known to interact with herbal supplements like St. John's Wort?

Official guidance requires avoiding Lesetrin use with alcohol and other Central Nervous System (CNS) depressants because of a risk of additive drowsiness and reduced alertness. Since certain herbal supplements, such as St. John's Wort, are known to potentially affect the CNS, caution is advised.

Q: Why does the official information mention a risk for condition Z?

Official safety documents include a warning about the risk of severe pruritus (intense itching) that may occur after a patient stops taking the medicine daily for a long period. This risk has been reported in post-marketing surveillance.

Q: What should I do if a side effect seems to be getting worse?

The official patient information describes conditions that warrant seeking immediate medical attention, such as signs of a serious adverse reaction. This includes symptoms such as hives, severe rash, significant swelling, or other signs consistent with an allergic reaction.

Q: Is Lesetrin a controlled substance?

Lesetrin is classified as a second-generation antihistamine. It is not currently listed as a controlled substance under federal drug schedules.

Q: Do older adults react differently to Lesetrin compared to younger people?

Pharmacokinetic studies show that older adults (aged 65-74) may clear the drug from their bodies at a reduced rate compared to younger adults. This difference is primarily due to the drug’s dependence on renal (kidney) function for disposal, and dose adjustments are recommended for older patients with kidney impairment.

Q: Can Lesetrin make other existing health conditions worse?

Official warnings advise caution for use in individuals with existing health factors that predispose them to urinary retention or for patients who have epilepsy. The warnings note the potential risk of worsening these existing conditions. There is also a greater risk of adverse effects for those with kidney impairment.

Q: Are there any specific lifestyle changes suggested while on Lesetrin?

Official guidance advises caution with activities that require full mental alertness, such as driving or operating heavy machinery, until the individual is aware of how the medicine affects them. Official guidance carries a warning about avoiding the use of alcohol or other Central Nervous System depressants.

How should Lesetrin be stored and disposed of?

Storage and Disposal of Lesetrin

The storage of Lesetrin (Levocetirizine dihydrochloride) must strictly follow official regulatory requirements to maintain product integrity.

Storage Requirements

Condition	Requirement
Temperature	Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F).
Protection	Keep the original container tightly closed to protect the product from light and moisture. The oral solution formulation must not be frozen.
Child Safety	The medicine must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Lesetrin must be disposed of according to local pharmaceutical waste regulations. The preferred method is to use a community drug take-back program. If such a program is unavailable, unused medication should be mixed with an undesirable substance (such as dirt or coffee grounds) and sealed in a container before being placed in household trash. Do not flush Lesetrin down the toilet or sink.

Lesetrin